{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:25:41Z","timestamp":1787217941328,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04207-3","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:48:57Z","timestamp":1787215737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Faricimab for treatment-na\u00efve nAMD: 1- and 2-year outcomes and PS-OCT polarimetric entropy"],"prefix":"10.1007","volume":"46","author":[{"given":"Teruki","family":"Katabami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohdai","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9998-7448","authenticated-orcid":false,"given":"Keiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"4207_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"T Wong","year":"2008","unstructured":"Wong T et al (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116\u2013126","journal-title":"Ophthalmology"},{"key":"4207_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"4207_CR3","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s00417-022-05716-4","volume":"260","author":"S Sadda","year":"2022","unstructured":"Sadda S et al (2022) Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysis. Graefes Arch Clin Exp Ophthalmol 260:3781\u20133789","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4207_CR4","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41433-020-0799-y","volume":"34","author":"U Chakravarthy","year":"2020","unstructured":"Chakravarthy U et al (2020) Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration. Eye (Lond) 34:2249\u20132256","journal-title":"Eye (Lond)"},{"key":"4207_CR5","first-page":"87","volume":"29","author":"C Paterson","year":"2023","unstructured":"Paterson C, Cannon J, Vargis E (2023) The impact of early RPE cell junction loss on VEGF, Ang-2, and TIMP secretion in vitro. Mol Vis 29:87\u2013101","journal-title":"Mol Vis"},{"key":"4207_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845\u2013881","journal-title":"Physiol Rev"},{"key":"4207_CR7","doi-asserted-by":"publisher","first-page":"190724","DOI":"10.1155\/2010\/190724","volume":"2010","author":"R Sim\u00f3","year":"2010","unstructured":"Sim\u00f3 R, Villarroel M, Corraliza L, Hern\u00e1ndez C, Garcia-Ram\u00edrez M (2010) The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier\u2013implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010:190724. https:\/\/doi.org\/10.1155\/2010\/190724","journal-title":"J Biomed Biotechnol"},{"key":"4207_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-023-02699-9","volume":"20","author":"S Augustin","year":"2023","unstructured":"Augustin S et al (2023) Melanophages give rise to hyperreflective foci in AMD, a disease-progression marker. J Neuroinflamm 20:28. https:\/\/doi.org\/10.1186\/s12974-023-02699-9","journal-title":"J Neuroinflamm"},{"key":"4207_CR9","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2024.02.014","volume":"131","author":"AM Khanani","year":"2024","unstructured":"Khanani AM et al (2024) Tenaya and Lucerne: two-year results from the phase 3 neovascular age-related macular degeneration trials of faricimab with treat-and-extend dosing in year 2. Ophthalmology 131:914\u2013926","journal-title":"Ophthalmology"},{"key":"4207_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10384-023-01040-4","volume":"68","author":"H Matsumoto","year":"2024","unstructured":"Matsumoto H, Hoshino J, Nakamura K, Akiyama H (2024) One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-na\u00efve neovascular age-related macular degeneration. Jpn J Ophthalmol 68:83\u201390","journal-title":"Jpn J Ophthalmol"},{"key":"4207_CR11","doi-asserted-by":"publisher","first-page":"11681","DOI":"10.1038\/s41598-024-62559-1","volume":"14","author":"R Mukai","year":"2024","unstructured":"Mukai R et al (2024) One-year outcomes and safety assessment of faricimab in treatment-na\u00efve patients with neovascular age-related macular degeneration in Japan. Sci Rep 14:11681. https:\/\/doi.org\/10.1038\/s41598-024-62559-1","journal-title":"Sci Rep"},{"key":"4207_CR12","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1038\/s41598-020-64601-4","volume":"10","author":"M Matsuzaki","year":"2020","unstructured":"Matsuzaki M et al (2020) Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium. Sci Rep 10:7656. https:\/\/doi.org\/10.1038\/s41598-020-64601-4","journal-title":"Sci Rep"},{"key":"4207_CR13","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1038\/s41598-022-11192-x","volume":"12","author":"D Sakai","year":"2022","unstructured":"Sakai D et al (2022) Retinal pigment epithelium melanin imaging using polarization-sensitive optical coherence tomography for patients with retinitis pigmentosa. Sci Rep 12:7115. https:\/\/doi.org\/10.1038\/s41598-022-11192-x","journal-title":"Sci Rep"},{"key":"4207_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-025-06995-3","author":"R Terao","year":"2025","unstructured":"Terao R et al (2025) Short-term changes in retinal pigment epithelium after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration evaluated by polarization-sensitive optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-025-06995-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4207_CR15","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1364\/BOE.7.003551","volume":"7","author":"M Yamanari","year":"2016","unstructured":"Yamanari M et al (2016) Estimation of Jones matrix, birefringence and entropy using Cloude-Pottier decomposition in polarization-sensitive optical coherence tomography. Biomed Opt Express 7:3551\u20133573","journal-title":"Biomed Opt Express"},{"key":"4207_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1109\/TPAMI.2017.2699184","volume":"40","author":"L-C Chen","year":"2018","unstructured":"Chen L-C, Papandreou G, Kokkinos I, Murphy K, Yuille AL (2018) DeepLab: semantic image segmentation with deep convolutional nets, atrous convolution, and fully connected CRFs. IEEE Trans Pattern Anal Mach Intell 40:834\u2013848","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"4207_CR17","doi-asserted-by":"publisher","first-page":"100792","DOI":"10.1016\/j.xops.2025.100792","volume":"5","author":"R Terao","year":"2025","unstructured":"Terao R et al (2025) Quantification of hyperreflective foci in age-related macular degeneration by polarization-sensitive OCT. Ophthalmol Sci 5:100792. https:\/\/doi.org\/10.1016\/j.xops.2025.100792","journal-title":"Ophthalmol Sci"},{"key":"4207_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/24741264251352888","author":"K Okawa","year":"2025","unstructured":"Okawa K et al (2025) One-year outcomes of intravitreal faricimab injection in treatment-na\u00efve patients with neovascular age-related macular degeneration. J Vitreoretin Dis. https:\/\/doi.org\/10.1177\/24741264251352888","journal-title":"J Vitreoretin Dis"},{"key":"4207_CR19","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s00417-022-05586-w","volume":"260","author":"KB Freund","year":"2022","unstructured":"Freund KB et al (2022) Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR. Graefes Arch Clin Exp Ophthalmol 260:2437\u20132447","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4207_CR20","doi-asserted-by":"publisher","first-page":"22346","DOI":"10.1038\/s41598-024-72670-y","volume":"14","author":"JH Kim","year":"2024","unstructured":"Kim JH, Park SM, Kim JW, Kim CG (2024) Clinical characteristics and long-term treatment outcomes of polypoidal choroidal vasculopathy with classic type leakage. Sci Rep 14:22346. https:\/\/doi.org\/10.1038\/s41598-024-72670-y","journal-title":"Sci Rep"},{"key":"4207_CR21","first-page":"431","volume":"23","author":"F Farjood","year":"2017","unstructured":"Farjood F, Vargis E (2017) Physical disruption of cell-cell contact induces VEGF expression in RPE cells. Mol Vis 23:431\u2013446","journal-title":"Mol Vis"},{"key":"4207_CR22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","volume":"35","author":"AM Joussen","year":"2021","unstructured":"Joussen AM et al (2021) Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye (Lond) 35:1305\u20131316","journal-title":"Eye (Lond)"},{"key":"4207_CR23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1364\/BOE.3.001670","volume":"3","author":"B Baumann","year":"2012","unstructured":"Baumann B et al (2012) Polarization sensitive optical coherence tomography of melanin provides intrinsic contrast based on depolarization. Biomed Opt Express 3:1670\u20131683","journal-title":"Biomed Opt Express"},{"key":"4207_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.exer.2007.08.010","volume":"85","author":"Z Ablonczy","year":"2007","unstructured":"Ablonczy Z, Crosson CE (2007) VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res 85:762\u2013771","journal-title":"Exp Eye Res"},{"key":"4207_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajo.2021.11.020","volume":"238","author":"O Nanegrungsunk","year":"2022","unstructured":"Nanegrungsunk O et al (2022) Correlation of change in central subfield thickness and change in visual acuity in neovascular AMD: post hoc analysis of VIEW 1 and 2. Am J Ophthalmol 238:97\u2013102","journal-title":"Am J Ophthalmol"},{"key":"4207_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/aos.16799","volume":"103","author":"V Mares","year":"2025","unstructured":"Mares V et al (2025) Correlation of retinal fluid and photoreceptor and RPE loss in neovascular AMD by automated quantification, a real-world FRB! analysis. Acta Ophthalmol 103:295\u2013303","journal-title":"Acta Ophthalmol"},{"key":"4207_CR27","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1038\/s41433-022-02360-4","volume":"37","author":"RLW Hanson","year":"2023","unstructured":"Hanson RLW, Airody A, Sivaprasad S, Gale RP (2023) Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review. Eye (Lond) 37:2438\u20132453","journal-title":"Eye (Lond)"},{"key":"4207_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/bjophthalmol-2015-306607","volume":"100","author":"C Sch\u00fctze","year":"2016","unstructured":"Sch\u00fctze C et al (2016) Polarisation-sensitive OCT is useful for evaluating retinal pigment epithelial lesions in patients with neovascular AMD. Br J Ophthalmol 100:371\u2013377","journal-title":"Br J Ophthalmol"},{"key":"4207_CR29","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1167\/iovs.09-3817","volume":"51","author":"C Ahlers","year":"2010","unstructured":"Ahlers C et al (2010) Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci 51:2149\u20132157","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4207_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamaophthalmol.2020.1376","volume":"138","author":"SM Waldstein","year":"2020","unstructured":"Waldstein SM et al (2020) Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography. JAMA Ophthalmol 138:740\u2013747","journal-title":"JAMA Ophthalmol"},{"key":"4207_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00417-019-04546-1","volume":"258","author":"Y Hsia","year":"2020","unstructured":"Hsia Y et al (2020) Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 258:273\u2013280","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04207-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:48:59Z","timestamp":1787215739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04207-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4207"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04207-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Tokyo Hospital (Ethics Committee ID number: 11,822) and conducted in accordance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using an opt-out consent process approved by the Institutional Review Board of the University of Tokyo Hospital. Patients received information about the study and were given the opportunity to decline participation. The need for written informed consent was waived in accordance with institutional guidelines due to the retrospective nature of this study.Ethics declarations.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided consent for anonymized data and images to be used for publication in scientific journals.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"338"}}